Top

Neurological Sciences

Published in:

23-03-2022 | Magnetic Resonance Imaging | COVID-19

Anti-SARS-Cov2 vaccination at the time of the COVID-19 pandemic: suspected adverse events reporting is the milestone of post-marketing surveillance

Authors: Alice Mariottini, Anna Maria Repice, Alessandro Barilaro, Luca Massacesi

Published in: Neurological Sciences | Issue 7/2022

Excerpt

Dear Editor, …

Agency EM (2021) Vaxzevria (previously COVID-19 vaccine AstraZeneca). Available from: https://www.ema.europa.eu/en/medicines/human/EPAR/vaxzevria-previously-covid-19-vaccine-astrazeneca. Accessed 30 Sept 2021

Voysey M, Clemens SAC, Madhi SA et al (2021) Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet 397(10269):99–111. https://doi.org/10.1016/S0140-6736(20)32661-1[publishedOnlineFirst:2020/12/12]CrossRefPubMedPubMedCentral

Havla J, Schultz Y, Zimmermann H et al (2022) First manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine. J Neurol 269(1):55–58CrossRef

Nistri R, Barbuti E, Rinaldi V et al (2021) Case report: multiple sclerosis relapses after vaccination against SARS-CoV2: a series of clinical cases. Front Neurol 12:765954CrossRef

Khayat-Khoei M, Bhattacharyya S, Katz J et al (2021) COVID-19 mRNA vaccination leading to CNS inflammation: a case series. J Neurol:1–14. https://doi.org/10.1007/s00415-021-10780-7

Agency EM (2021) COVID-19 vaccine safety update. Available from: https://www.ema.europa.eu/en/documents/covid-19-vaccine-safety-update/covid-19-vaccine-safety-update-vaxzevria-previously-covid-19-vaccine-astrazeneca-8-september-2021_en.pdf. Accessed 30 Sept 2021

Title: Anti-SARS-Cov2 vaccination at the time of the COVID-19 pandemic: suspected adverse events reporting is the milestone of post-marketing surveillance
Authors: Alice Mariottini
Anna Maria Repice
Alessandro Barilaro
Luca Massacesi
Publication date: 23-03-2022
Publisher: Springer International Publishing
Keywords: Magnetic Resonance Imaging
Magnetic Resonance Imaging
Multiple Sclerosis
COVID-19 Vaccination
Vaccination
COVID-19
Published in: Neurological Sciences / Issue 7/2022
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI: https://doi.org/10.1007/s10072-022-05961-9

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Anti-SARS-Cov2 vaccination at the time of the COVID-19 pandemic: suspected adverse events reporting is the milestone of post-marketing surveillance

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 7/2022

Efficacy and safety of reperfusion treatments in middle-old and oldest-old stroke patients

Generalized myasthenia gravis patients infected with COVID-19 should continue eculizumab

The altered multiscale dynamics of spontaneous brain activity in depression with Parkinson’s disease

Common genetic basis of ALS patients and soccer players may contribute to disease risk

Essential tremor and cognitive impairment: who, how, and why

Development and validation of the Myasthenia Gravis TeleScore (MGTS)